Amarin Q2 net loss $14.1M; signs European licensing deal with Recordati, plans restructuring

AMARIN CORP PLCUK

2025-Q2 EPS reported -$0.07 revenue$114,757,000

Q2 net loss of $14.1M ($0.03 per share) vs. $1.5M net income in Q2 2024.
Total net revenue $72.7M (+8% YoY); licensing revenue up 31% on Recordati upfront.
Signed exclusive European licensing agreement with Recordati for VAZKEPA in 59 countries.
Global restructuring expected to deliver $70M in operating expense savings over 12 months.
Cash $298.7M, debt-free; U.S. product revenue down 17% to $36.5M, Europe up 85% to $6.6M.

item 2.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.